Notably, while EGFR is overexpressed in around 50% TNBC and inflammatory breast cancers [24], we found that this gene, as well as its ligand AREG, was downregulated in the luminal A obese group. This evidence concerns the gene EGFR and inflammatory breast carcinoma.